Urokinase
- TRADE NAMES: Abbokinase (AbbVie); Ukidan
- INDICATIONS: Acute myocardial infarction; coronary artery thrombosis; pulmonary embolism
- CLASS: Fibrinolytic, Plasminogen activator
- HALF-LIFE: 10–20 minutes
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aspirin, Bivalirudin, Ibuprofen, Indomethacin
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
HEMATOLOGIC.
OCULAR.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric